Drug confers benefits for subset of AML patientsApril 25, 2014Leukemia, Myelodysplasia, TransplantationAML
Leukemic breast tumors may cause resistance in AML, ALLApril 23, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALL
Embedded miRNA, not its host, drives AML, group saysApril 23, 2014Leukemia, Myelodysplasia, TransplantationAML
Team identifies potential treatment for FLT3-ITD AMLApril 22, 2014Leukemia, Myelodysplasia, TransplantationAML
Drug gets orphan designation for AMLApril 22, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
Molecule shows preclinical activity in leukemias, lymphomasApril 20, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
Dual kinase inhibitor targets heterogeneity in AMLApril 15, 2014Leukemia, Myelodysplasia, TransplantationAML
Compound is potent FLT3 inhibitor, team saysApril 10, 2014Leukemia, Myelodysplasia, TransplantationAML
Product gets orphan designation for AMLApril 4, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
Testing reveals abnormalities in CN-AML/MDSApril 2, 2014AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
CNS involvement doesn’t affect survival after allo-SCTMarch 5, 2014Leukemia, Myelodysplasia, TransplantationTransplantationAML
Drugs get orphan designation for AML, MMMarch 4, 2014Leukemia, Myelodysplasia, TransplantationMultiple MyelomaPharmacyAML
Investigating the cause of infant leukemiasFebruary 21, 2014Leukemia, Myelodysplasia, TransplantationPediatricsAMLALL
